• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同趋化因子通过趋化因子受体CCR5进行的多种信号传导。

Diverse signalling by different chemokines through the chemokine receptor CCR5.

作者信息

Mueller Anja, Mahmoud Nasir G, Strange Philip G

机构信息

School of Animal and Microbial Sciences, University of Reading, PO Box 228, Reading, RG6 6AJ, UK.

出版信息

Biochem Pharmacol. 2006 Sep 14;72(6):739-48. doi: 10.1016/j.bcp.2006.06.001. Epub 2006 Jul 17.

DOI:10.1016/j.bcp.2006.06.001
PMID:16844091
Abstract

We have investigated the signalling properties of the chemokine receptor, CCR5, using several assays for agonism: stimulation of changes in intracellular Ca(2+) or CCR5 internalisation in CHO cells expressing CCR5 or stimulation of [(35)S]GTPgammaS binding in membranes of CHO cells expressing CCR5. Four isoforms of the chemokine CCL3 with different amino termini (CCL3, CCL3(2-70), CCL3(5-70), CCL3L1) were tested in these assays in order to probe structure/activity relationships. Each isoform exhibited agonism. The pattern of agonism (potency, maximal effect) was different in the three assays, although the rank order was the same with CCL3L1 being the most potent and efficacious. The data show that the amino terminus of the chemokine is important for signalling. A proline at position 2 (CCL3L1) provides for high potency and efficacy but the isoform with a serine at position 2 (CCL3(2-70)) is as efficacious in some assays showing that the proline is not the only determinant of high efficacy. We also increased the sensitivity of CCR5 signalling by treating cells with sodium butyrate, thus increasing the receptor/G protein ratio. This allowed the detection of a change in intracellular Ca(2+) after treatment with CCL7 and Met-RANTES showing that these ligands possess measurable but low efficacy. This study therefore shows that sodium butyrate treatment increases the sensitivity of signalling assays and enables the detection of efficacy in ligands previously considered as antagonists. The use of different assay systems, therefore, provides different estimates of efficacy for some ligands at this receptor.

摘要

我们使用了多种激动作用检测方法,对趋化因子受体CCR5的信号传导特性进行了研究:检测表达CCR5的CHO细胞内钙离子(Ca(2+))变化、CCR5内化情况,或检测表达CCR5的CHO细胞膜中[(35)S]GTPγS结合情况。为了探究结构/活性关系,我们在这些检测中对具有不同氨基末端的趋化因子CCL3的四种同工型(CCL3、CCL3(2 - 70)、CCL3(5 - 70)、CCL3L1)进行了测试。每种同工型均表现出激动作用。尽管在三种检测中激动作用的排序相同,CCL3L1最为强效且有效,但激动作用模式(效力、最大效应)有所不同。数据表明趋化因子的氨基末端对信号传导很重要。第2位为脯氨酸的同工型(CCL3L1)具有高效力和高活性,但第2位为丝氨酸的同工型(CCL3(2 - 70))在某些检测中同样有效,这表明脯氨酸并非高效力的唯一决定因素。我们还通过用丁酸钠处理细胞来提高CCR5信号传导的敏感性,从而增加受体/G蛋白比率。这使得在用CCL7和甲硫氨酸-RANTES处理后能够检测到细胞内钙离子(Ca(2+))的变化,表明这些配体具有可测量但较低的活性。因此,本研究表明丁酸钠处理可提高信号传导检测的敏感性,并能够检测到先前被视为拮抗剂的配体的活性。所以,使用不同的检测系统会对某些配体在该受体上的活性给出不同的评估。

相似文献

1
Diverse signalling by different chemokines through the chemokine receptor CCR5.不同趋化因子通过趋化因子受体CCR5进行的多种信号传导。
Biochem Pharmacol. 2006 Sep 14;72(6):739-48. doi: 10.1016/j.bcp.2006.06.001. Epub 2006 Jul 17.
2
Analysis of second messenger pathways stimulated by different chemokines acting at the chemokine receptor CCR5.作用于趋化因子受体CCR5的不同趋化因子所刺激的第二信使途径分析。
Biochem Pharmacol. 2007 Sep 15;74(6):881-90. doi: 10.1016/j.bcp.2007.06.019. Epub 2007 Jun 20.
3
Allosteric effects of antagonists on signalling by the chemokine receptor CCR5.拮抗剂对趋化因子受体CCR5信号传导的变构效应。
Biochem Pharmacol. 2007 Sep 15;74(6):891-7. doi: 10.1016/j.bcp.2007.06.032. Epub 2007 Jun 26.
4
CCR5 internalisation and signalling have different dependence on membrane lipid raft integrity.CCR5内化和信号传导对膜脂筏完整性有不同的依赖性。
Cell Signal. 2008 Sep;20(9):1687-94. doi: 10.1016/j.cellsig.2008.05.014. Epub 2008 Jun 3.
5
An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.CC趋化因子G蛋白偶联受体CCR4和CCR5的一类特定拮抗剂的细胞内变构位点。
Mol Pharmacol. 2008 Mar;73(3):855-67. doi: 10.1124/mol.107.039321. Epub 2007 Nov 27.
6
Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers.CCR5-CCR2b异二聚体内负性结合协同性的证据。
Mol Pharmacol. 2005 Feb;67(2):460-9. doi: 10.1124/mol.104.003624. Epub 2004 Oct 27.
7
Distinct modes of molecular regulation of CCL3 induced calcium flux in monocytic cells.单核细胞中CCL3诱导钙通量的不同分子调控模式。
Biochem Pharmacol. 2009 Oct 15;78(8):974-82. doi: 10.1016/j.bcp.2009.06.003. Epub 2009 Jun 10.
8
Chemokine receptor CCR5 deficiency exacerbates cerulein-induced acute pancreatitis in mice.趋化因子受体CCR5缺陷会加重小鼠中蛙皮素诱导的急性胰腺炎。
Am J Physiol Gastrointest Liver Physiol. 2006 Dec;291(6):G1089-99. doi: 10.1152/ajpgi.00571.2005. Epub 2006 Aug 3.
9
The molecular cloning and functional expression of the dog CCR5.犬CCR5的分子克隆与功能表达
Vet Immunol Immunopathol. 2006 Oct 15;113(3-4):415-20. doi: 10.1016/j.vetimm.2006.05.009. Epub 2006 Jun 27.
10
The activation mechanism of chemokine receptor CCR5 involves common structural changes but a different network of interhelical interactions relative to rhodopsin.趋化因子受体CCR5的激活机制涉及常见的结构变化,但相对于视紫红质而言,其螺旋间相互作用网络有所不同。
Cell Signal. 2007 Jul;19(7):1446-56. doi: 10.1016/j.cellsig.2007.01.022. Epub 2007 Jan 25.

引用本文的文献

1
Co-receptor signaling in the pathogenesis of neuroHIV.共受体信号在神经 HIV 发病机制中的作用。
Retrovirology. 2021 Aug 24;18(1):24. doi: 10.1186/s12977-021-00569-x.
2
Chemokine receptor CXCR4 oligomerization is disrupted selectively by the antagonist ligand IT1t.趋化因子受体CXCR4的寡聚化被拮抗剂配体IT1t选择性破坏。
J Biol Chem. 2021 Jan-Jun;296:100139. doi: 10.1074/jbc.RA120.016612. Epub 2020 Dec 6.
3
Entanglement of CCR5 and Alzheimer's Disease.CCR5与阿尔茨海默病的关联
Front Aging Neurosci. 2019 Aug 7;11:209. doi: 10.3389/fnagi.2019.00209. eCollection 2019.
4
Spatial intensity distribution analysis quantifies the extent and regulation of homodimerization of the secretin receptor.空间强度分布分析可量化促胰液素受体同源二聚化的程度及调控情况。
Biochem J. 2017 May 24;474(11):1879-1895. doi: 10.1042/BCJ20170184.
5
Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry.以靶向备用C-C趋化因子受体5(CCR5)作为抑制HIV-1进入的原则。
J Biol Chem. 2014 Jul 4;289(27):19042-52. doi: 10.1074/jbc.M114.559831. Epub 2014 May 22.
6
HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines.HIV-1 利用 CCR5 构象异质性来逃避趋化因子的抑制。
Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9475-80. doi: 10.1073/pnas.1222205110. Epub 2013 May 21.
7
A novel highly potent therapeutic antibody neutralizes multiple human chemokines and mimics viral immune modulation.一种新型高效治疗性抗体可中和多种人趋化因子并模拟病毒免疫调节。
PLoS One. 2012;7(8):e43332. doi: 10.1371/journal.pone.0043332. Epub 2012 Aug 17.
8
Pivotal role of the CCL5/CCR5 interaction for recruitment of endothelial progenitor cells in mouse wound healing.CCL5/CCR5 相互作用在招募内皮祖细胞参与小鼠伤口愈合中的关键作用。
J Clin Invest. 2012 Feb;122(2):711-21. doi: 10.1172/JCI43027. Epub 2012 Jan 3.
9
Plasmid transduction using bacteriophage Phi(adh) for expression of CC chemokines by Lactobacillus gasseri ADH.利用噬菌体 Phi(adh)进行质粒转导,通过乳杆菌 ADH 表达 CC 趋化因子。
Appl Environ Microbiol. 2010 Jun;76(12):3878-85. doi: 10.1128/AEM.00139-10. Epub 2010 Apr 23.
10
Control of feeding behavior in C. elegans by human G protein-coupled receptors permits screening for agonist-expressing bacteria.人类G蛋白偶联受体对秀丽隐杆线虫进食行为的控制允许筛选表达激动剂的细菌。
Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):14826-31. doi: 10.1073/pnas.0803290105. Epub 2008 Sep 24.